These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 10133463

  • 1. Target drug monitoring: a cost-effective service provided by staff pharmacists.
    Chrymko MM, Meyer JD, Kelly WN.
    Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
    [Abstract] [Full Text] [Related]

  • 2. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA.
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. How to develop a successful DUE (drug usage evaluation) program: experience of a teaching medical center.
    Cheung MO.
    Hosp Formul; 1994 Feb; 29(2):137-9, 142-3, 145. PubMed ID: 10131876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. How a CQI program improved aminoglycoside use in a community hospital.
    Wade WE, McCall CY.
    Hosp Formul; 1995 Feb; 30(2):114-6. PubMed ID: 10140350
    [Abstract] [Full Text] [Related]

  • 8. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW, Keith TD, Foster MT.
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [Abstract] [Full Text] [Related]

  • 9. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA, Henderson PL, Newman RB, Blackwelder EN, Caldwell RD.
    Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
    [Abstract] [Full Text] [Related]

  • 10. Evaluating the value, accuracy, and operational feasibility of DUE criteria.
    Ben-Joseph R, Segal R, Russell WL, Oh T.
    Formulary; 1995 May; 30(5):280-3. PubMed ID: 10151727
    [Abstract] [Full Text] [Related]

  • 11. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA, Chow MS, Jay GT, Quintiliani R.
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [Abstract] [Full Text] [Related]

  • 12. Warfarin: a quality assurance model for concurrent drug monitoring.
    Mattei TJ, Karnack CM, Rihn TL, Eder RA.
    Hosp Pharm; 1985 Apr; 20(4):235-7, 240-1. PubMed ID: 10270729
    [Abstract] [Full Text] [Related]

  • 13. Documenting concurrent clinical pharmacy interventions.
    Haslett TM, Kay BG, Weissfellner H.
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH, Sterba KJ, Szymusiak-Mutnick BA.
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [Abstract] [Full Text] [Related]

  • 16. Continuous quality assurance monitoring by staff pharmacists.
    Spradling GF.
    Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
    [Abstract] [Full Text] [Related]

  • 17. Assuring the quality of a clinical pharmacokinetics service.
    Waller DJ, Smith SR.
    Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
    [Abstract] [Full Text] [Related]

  • 18. Revising a drug information center quality assurance program to conform to Joint Commission standards.
    Moody ML.
    Am J Hosp Pharm; 1990 Apr; 47(4):792-4. PubMed ID: 2321654
    [Abstract] [Full Text] [Related]

  • 19. Developing and implementing guidelines to promote appropriate use of fluconazole therapy in an AIDS clinic.
    Anassi EO, Egbunike IG, Akpaffiong MJ, Ike EN, Cate TR.
    Hosp Pharm; 1994 Jun; 29(6):576-8, 581-2, 585-6. PubMed ID: 10134178
    [Abstract] [Full Text] [Related]

  • 20. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF, Halvachs FJ.
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.